TG Therapeutics Is Still A Buy And Their Buyback Program Is Still Too Conservative

Word Count: 2,880 words, Reading Time: 13 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.

Subscribers: Substack is telling me this post is too long for email so please load in browser if the bottom cuts off before my signature.

I wrote about TG Therapeutics TGTX 0.00%↑ on May 27:

TG Therapeutics Should Increase Their Share Buyback Authorization Immediately

At the time the stock was trading at $34.57. My main thesis was based on the explosive growth of their product BRIUMVI the company should be…